51.1 F
New York
Monday, November 28, 2022



Co-Chairs from Aerie Pharmaceuticals & Santen Inc. USA Invite Industry Experts to Join Ophthalmic Drugs

Related Articles

ClinicalPURSUIT Offers Free Demonstration to Help Clinical Research Understand Their System and How It Can Help During Clinical Trials

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are expensive to conduct but are also essential in modern medicinal and therapeutic development. There is a...

ClinicalPURSUIT’s Software Offers Interactive Randomization Technology and RTSM to Help Researchers Conduct Flawless Clinical Research

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are crucial to developing modern medicines and therapeutic treatments. These research and trials are expected to be...

ClinicalPURSUIT’s Configurable Dashboards Assists Researchers in Conducting Clinical Research

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are fundamental to the success of modern medicinal and therapeutic development. However, there is a great need...
London, United Kingdom, October 28, 2022 –(PR.com)– The 5th Annual Ophthalmic Drugs Conference will take place in London at the Copthorne Tara Hotel on 21 and 22 November 2022. This event is less than four weeks away.

The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drug delivery along with advancements in novel technologies. Further key areas will be gene therapy and Artificial Intelligence with developments on the latest drug pipelines and clinical trials.

The conference is co-chaired by Mitchell A. (Mitch) de Long who holds the position of vice president, Chemistry at Aerie Pharmaceuticals as well as Adjunct Professor of Chemistry at Duke University. Since Mitch helped to found Aerie as a Duke University spinout in 2005, Aerie has filed 5 INDs and 2 NDAs, with its first FDA approval coming in 2017 and…

Read more…

Popular Articles